Main Menu

Anchiano Therapeutics Ltd.

(NASDAQ CM: ANCN)

Rigrodsky Law, P.A. is investigating Anchiano Therapeutics Ltd. ("Anchiano") regarding possible breaches of fiduciary duties and other violations of law related to Anchiano's agreement to merge with Chemomab Ltd. ("Chemomab"). Under the terms of the agreement, Anchiano will issue a number of American Depository Shares of Anchiano to shareholders of Chemomab.  Upon the closing of the merger, shareholders of Chemomab are expected to own approximately 90% of the outstanding shares of Anchiano.  

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 01/20/2021


* Indicates a required field.

Back to Page